agatoxin-489 has been researched along with am 251 in 1 studies
| Studies (agatoxin-489) | Trials (agatoxin-489) | Recent Studies (post-2010) (agatoxin-489) | Studies (am 251) | Trials (am 251) | Recent Studies (post-2010) (am 251) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 948 | 1 | 507 |
| Protein | Taxonomy | agatoxin-489 (IC50) | am 251 (IC50) |
|---|---|---|---|
| Cannabinoid receptor 1 | Homo sapiens (human) | 0.0892 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alger, BE; Kim, J | 1 |
1 other study(ies) available for agatoxin-489 and am 251
| Article | Year |
|---|---|
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
Topics: Agatoxins; Animals; Arachidonic Acids; Benzamides; Benzoxazines; Biophysics; Calcium; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Carbamates; Conotoxins; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glycerides; Hippocampus; Homeostasis; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Morpholines; Naphthalenes; Nerve Net; Neural Inhibition; Neurons; Patch-Clamp Techniques; Piperidines; Polyamines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Sodium Channel Blockers; Synapses; Tetrodotoxin | 2010 |